Add to ORKGBackground: HBV vaccination is recommended in HIV-infected adults with CD4+ cell count>200/mm3 although the efficacy is only 33.3 %-65%. We conducted a randomized, controlled trial to evaluate the efficacy and safety of three regimens of HBV vaccination at Chiang Mai University Hospital, Thailand. Methods: From February 4, 2011 to May 4, 2012, 132 HIV-infected adults with CD4+ cell counts>200 cells/mm3
Subjects at risk of infection with human immunodeficiency virus (HIV) are also at high risk of acute...
Equipe CHU UB (EA) Pôle MERS CT3 Hors Enjeu ANRS HB04 B-BOOST study group : Hugues Aumaitre (Centre ...
Background and Objective: HBV infection is preventable by effective vaccination in general populatio...
HBV vaccination is recommended in HIV-infected adults with CD4+ cell count >200/mm(3) although the e...
<div><p>Background</p><p>HBV vaccination is recommended in HIV-infected adults with CD4+ cell count ...
although the efficacy is only 33.3% -65%. We conducted a randomized, controlled trial to evaluate t...
SummaryBackgroundVaccination against hepatitis B virus (HBV) has been recommended for all high-risk ...
Hepatitis B and A account for considerable morbidity and mortality worldwide. Immuni...
Abstract Background Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV)...
[Background] HIV-infected patients are at risk of hepatitis B virus (HBV) coinfection, however, resp...
There is no consensus regarding a best dosing regimen of hepatitis B virus vaccine (HBVV) for non-re...
Introduction and aim: Viral hepatitis is a serious public health problem. The risk of progression to...
Objectives: Prevention of hepatitis B virus (HBV) infection is necessary for patients with humanimmu...
The purpose of this prospective cohort study was to compare the serologic response between human imm...
There is no consensus regarding a best dosing regimen of hepatitis B virus vaccine (HBVV) for non-re...
Subjects at risk of infection with human immunodeficiency virus (HIV) are also at high risk of acute...
Equipe CHU UB (EA) Pôle MERS CT3 Hors Enjeu ANRS HB04 B-BOOST study group : Hugues Aumaitre (Centre ...
Background and Objective: HBV infection is preventable by effective vaccination in general populatio...
HBV vaccination is recommended in HIV-infected adults with CD4+ cell count >200/mm(3) although the e...
<div><p>Background</p><p>HBV vaccination is recommended in HIV-infected adults with CD4+ cell count ...
although the efficacy is only 33.3% -65%. We conducted a randomized, controlled trial to evaluate t...
SummaryBackgroundVaccination against hepatitis B virus (HBV) has been recommended for all high-risk ...
Hepatitis B and A account for considerable morbidity and mortality worldwide. Immuni...
Abstract Background Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV)...
[Background] HIV-infected patients are at risk of hepatitis B virus (HBV) coinfection, however, resp...
There is no consensus regarding a best dosing regimen of hepatitis B virus vaccine (HBVV) for non-re...
Introduction and aim: Viral hepatitis is a serious public health problem. The risk of progression to...
Objectives: Prevention of hepatitis B virus (HBV) infection is necessary for patients with humanimmu...
The purpose of this prospective cohort study was to compare the serologic response between human imm...
There is no consensus regarding a best dosing regimen of hepatitis B virus vaccine (HBVV) for non-re...
Subjects at risk of infection with human immunodeficiency virus (HIV) are also at high risk of acute...
Equipe CHU UB (EA) Pôle MERS CT3 Hors Enjeu ANRS HB04 B-BOOST study group : Hugues Aumaitre (Centre ...
Background and Objective: HBV infection is preventable by effective vaccination in general populatio...